‘Remdesivir not magic bullet’: AIIMS director on antiviral drug use in Covid

Video Credit: HT Digital Content
Published 3 weeks ago - Duration: 02:43s

Remdesivir not magic bullet’: AIIMS director on antiviral drug use in Covid

Amid a steep spike in COVID-19 cases leading to increased demand for medicines for treating coronavirus, top health experts in the government on Monday said anti-viral drug remdesivir is "not a magic bullet" and does not reduce mortality.

"Remdesivir is not a magic bullet and this is not a drug that reduces mortality.

We may use it as we don't have a very good antiviral drug.

It has a limited role and we should be very careful in its usage," he said.

Watch the full video for more details.


You are here


💡 newsR Knowledge: Other News Mentions



All India Institute of Medical Sciences, New Delhi

Medical School, Hospital and Public Medical Research University situated in New Delhi, India
The trial will take place in 525 subjects at various sites, including AIIMS Delhi, AIIMS Patna and Meditrina Institute of Medical Sciences, Nagpur.
Credit: DNA - Published 21 hours ago

The ministry of external affair's COVID cell is working 24*7 and a standard operating procedure has been set up to smoothen delivery of assistance.
Credit: DNA - Published 4 days ago

Related videos from verified sources

Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen 03:24
Video credit: HT Digital Content - Published 4 days ago 

DCGI approves DRDO's anti-COVID drug helpful in faster recovery 02:44
Video credit: ANI - Published 5 days ago 

Hundreds queue at government counter selling drug used to treat COVID-19 in India 01:56
Video credit: Newsflare STUDIO - Published 1 week ago 

You might like